UB Paderborn / Katalog / Suche / in CDI

Using Cost-Effectiveness Analysis to Address Health Equity Concerns

Value in health, 2017-02, Vol.20 (2), p.206-212

2017

Volltextzugriff (PDF)

The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought

Value in health, 2016-12, Vol.19 (8), p.921-928

2016

Volltextzugriff (PDF)

Reinforcing Science and Policy, With Suggestions for Future Research Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide"

International journal of health policy and management, 2023-01, Vol.12 (1), p.7398-7398

Culyer, Anthony J

2023

Volltextzugriff (PDF)

Use of Evidence-Informed Deliberative Processes - Learning by Doing Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"

International journal of health policy and management, 2020-06, Vol.9 (6), p.263-265

Culyer, Anthony J

2020

Volltextzugriff (PDF)

Prevention of non-communicable disease: best buys, wasted buys, and contestable buys

BMJ (Online), 2020-01, Vol.368, p.m141

2020

Volltextzugriff (PDF)

Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making

Cost effectiveness and resource allocation, 2021-09, Vol.19 (1), p.62-62, Article 62

2021

Volltextzugriff (PDF)

Discounting and decision making in the economic evaluation of health-care technologies

Health economics, 2011-01, Vol.20 (1), p.2-15

2011

Volltextzugriff (PDF)

Expanding HTA - Correcting a Misattribution, Clarifying the Scope of HTA and CEA Comment on "Ethics in HTA: Examining the 'Need for Expansion'"

International journal of health policy and management, 2019-12, Vol.8 (12), p.732-733

Culyer, Anthony J

2019

Volltextzugriff (PDF)

Evidence-informed capacity building for setting health priorities in low- and middle-income countries: A framework and recommendations for further research [version 1; peer review: 2 approved]

F1000 research, 2017, Vol.6, p.231-231

2017

Volltextzugriff (PDF)

HTA - Algorithm or Process? Comment on "Expanded HTA: Enhancing Fairness and Legitimacy"

International journal of health policy and management, 2016-08, Vol.5 (8), p.501-505

Culyer, Anthony J

2016

Volltextzugriff (PDF)

Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use

Health economics, policy and law, 2016-10, Vol.11 (4), p.415-432

Culyer, Anthony J.

2016

Volltextzugriff (PDF)

Distributional Cost-Effectiveness Analysis Comes of Age

Value in health, 2021-01, Vol.24 (1), p.118-120

2021

Volltextzugriff (PDF)

Making Choices on the Journey to Universal Health Care Coverage: From Advocacy to Analysis

Value in health, 2016-12, Vol.19 (8), p.910-912

2016

Volltextzugriff (PDF)

The NICE Cost-Effectiveness Threshold: What it is and What that Means

PharmacoEconomics, 2008-01, Vol.26 (9), p.733-744

2008

Volltextzugriff (PDF)

Economic Evaluation for Health Investments En Route to Universal Health Coverage: Cost-Benefit Analysis or Cost-Effectiveness Analysis?

Value in health, 2019-01, Vol.22 (1), p.99-103

2019

Volltextzugriff (PDF)

COST, CONTEXT, AND DECISIONS IN HEALTH ECONOMICS AND HEALTH TECHNOLOGY ASSESSMENT

International journal of technology assessment in health care, 2018-01, Vol.34 (5), p.434-441

Culyer, Anthony J.

2018

Volltextzugriff (PDF)

Health Technology Assessment: Global Advocacy and Local Realities Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness"

International journal of health policy and management, 2017-04, Vol.6 (4), p.233-236

2017

Volltextzugriff (PDF)

Priority-setting for achieving universal health coverage

Bulletin of the World Health Organization, 2016-06, Vol.94 (6), p.462-467

2016

Volltextzugriff (PDF)

CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS?

Health economics, 2015-01, Vol.24 (1), p.1-7

2015

Volltextzugriff (PDF)

National Institute for Clinical Excellence and its value judgments

BMJ (Online), 2004-07, Vol.329 (7459), p.224-227

International edition, 2004

Volltextzugriff (PDF)

Four decades of health economics through a bibliometric lens

Journal of health economics, 2012-03, Vol.31 (2), p.406-439

2012

Volltextzugriff (PDF)

Economic Analysis of Vaccination Programs

Value in health, 2018-10, Vol.21 (10), p.1133

2018

Volltextzugriff (PDF)

Disease Control Priorities Third Edition: Time to Put a Theory of Change Into Practice Comment on "Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy"

International journal of health policy and management, 2019-02, Vol.8 (2), p.132-135

2019

Volltextzugriff (PDF)

A Systematic Review of Demand-Side Methods of Estimating the Societal Monetary Value of Health Gain

Value in health, 2021-10, Vol.24 (10), p.1423-1434

2021

Volltextzugriff (PDF)

Equity - some theory and its policy implications

Journal of medical ethics, 2001-08, Vol.27 (4), p.275-283

Culyer, Anthony J

2001

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Using Cost-Effectiveness Analysis to Address Health Equity Concerns

The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought

Reinforcing Science and Policy, With Suggestions for Future Research Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide"

Use of Evidence-Informed Deliberative Processes - Learning by Doing Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"

Prevention of non-communicable disease: best buys, wasted buys, and contestable buys

Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making

Discounting and decision making in the economic evaluation of health-care technologies

Expanding HTA - Correcting a Misattribution, Clarifying the Scope of HTA and CEA Comment on "Ethics in HTA: Examining the 'Need for Expansion'"

Evidence-informed capacity building for setting health priorities in low- and middle-income countries: A framework and recommendations for further research [version 1; peer review: 2 approved]

HTA - Algorithm or Process? Comment on "Expanded HTA: Enhancing Fairness and Legitimacy"

Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use

Distributional Cost-Effectiveness Analysis Comes of Age

Making Choices on the Journey to Universal Health Care Coverage: From Advocacy to Analysis

The NICE Cost-Effectiveness Threshold: What it is and What that Means

Economic Evaluation for Health Investments En Route to Universal Health Coverage: Cost-Benefit Analysis or Cost-Effectiveness Analysis?

COST, CONTEXT, AND DECISIONS IN HEALTH ECONOMICS AND HEALTH TECHNOLOGY ASSESSMENT

Health Technology Assessment: Global Advocacy and Local Realities Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness"

Priority-setting for achieving universal health coverage

CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS?

National Institute for Clinical Excellence and its value judgments

Four decades of health economics through a bibliometric lens

Economic Analysis of Vaccination Programs

Disease Control Priorities Third Edition: Time to Put a Theory of Change Into Practice Comment on "Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy"

A Systematic Review of Demand-Side Methods of Estimating the Societal Monetary Value of Health Gain

Equity - some theory and its policy implications

Suchergebnisse filtern